Diversified Consumer Services
Company Overview of The University of Texas M. D. Anderson Cancer Center
The University of Texas M. D. Anderson Cancer Center is an educational institution that offers undergraduate and research programs to physicians, biomedical scientists, and other health-care professionals. The departments include behavioral medicine, biochemistry and molecular biology, cancer biology program, cancer genomics core laboratory, molecular and cellular oncology, molecular genetics, molecular hematology and therapy, molecular therapeutics, and molecular pathology. The University of Texas M. D. Anderson Cancer Center was founded in 1941 as Texas State Cancer Hospital and the Division of Cancer Research and changed its name to M. D. Anderson Hospital for Cancer Research of The Unive...
1515 Holcombe Boulevard
Houston, TX 77030
Founded in 1989
Key Executives for The University of Texas M. D. Anderson Cancer Center
Executive Vice President and Physician-In-Chief
Chairman of Department of Health Disparities Research
Vice President and Head of the Division of Pharmacy
Compensation as of Fiscal Year 2013.
The University of Texas M. D. Anderson Cancer Center Key Developments
The University of Texas M. D. Anderson Cancer Center Inks Three-Year Agreement with Bayer HealthCare AG
Dec 11 13
The University of Texas M. D. Anderson Cancer Center has inked a three-year agreement with Bayer HealthCare AG. The two companies will collaborate in clinical programs and trials for the treatment of cancer. As part of the deal, the two organizations formed a joint committee that includes clinicians and scientists from Bayer HealthCare's sites in Berlin and Whippany, N.J., as well as from M.D. Anderson's Houston location. The committee will plan and conduct clinical trials with investigational anti-cancer treatments developed by Bayer HealthCare. The collaboration with M.D. Anderson will explore specific treatment approaches for common types of cancer including prostrate, colorectal and breast cancer, as well as rare forms, such as kidney, liver and thyroid cancer.
Bayer HealthCare Announces Collaboration with the University of Texas MD Anderson Cancer Center
Dec 11 13
Bayer HealthCare announced that the company has signed a master agreement for the performance of clinical trials with the University of Texas MD Anderson Cancer Center. The agreement aims to bolster ongoing and future collaborative clinical programs in oncology and bring new cancer treatments to patients. The growing oncology franchise of Bayer HealthCare explores specific treatment approaches for various tumors, including such common types of cancer as prostate, colorectal and breast cancer, as well as rarer forms like kidney, liver and thyroid cancer. MD Anderson Cancer Center ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The two organizations, as part of the agreement, have formed a joint committee comprising clinicians and scientists from Bayer HealthCare's sites in Berlin, Germany and Whippany, New Jersey and from MD Anderson in Houston, Texas, to plan and conduct clinical trials with investigational anti-cancer agents developed by Bayer HealthCare. As part of the company's overall innovation strategy, Bayer HealthCare is expanding its collaborative relationships with academia and life science firms all over the world.
Fujifilm Partners with MD Anderson Cancer Center on Three Oncology Candidates
Nov 26 13
Fujifilm has announced the formation of a clinical research partnership with United States-based cancer hospital the University of Texas MD Anderson Cancer Center. The partnership will focus on the development of three large-molecule oncology candidates - FF-10501, FF-10502, and FF-21101. All three will have Phase I and II clinical trials carried out at the MD Anderson Cancer Center. FF-10501 will be the first target for development, with a Phase I trial set to begin at the US hospital during the second quarter of 2014. No financial details were disclosed.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|